Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
- Authors
- 이용호; 조용인; 이병완; 박철영; 이대호; 차봉수; 이은정
- Issue Date
- Feb-2019
- Publisher
- 대한당뇨병학회
- Keywords
- Diabetes mellitus; Diagnosis; Epidemiology; Non-alcoholic fatty liver disease
- Citation
- Diabetes and Metabolism Journal, v.43, no.1, pp.31 - 45
- Journal Title
- Diabetes and Metabolism Journal
- Volume
- 43
- Number
- 1
- Start Page
- 31
- End Page
- 45
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/2647
- DOI
- 10.4093/dmj.2019.0011
- ISSN
- 2233-6079
- Abstract
- Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders whose prevalence rates are expected to rise worldwide, corresponding to aging and increasingly obese populations. Compared to the general population (around 25%), 50% to 70% of people with diabetes have NAFLD, and NAFLD severity (including fibrosis) tends to be worsened by the presence of diabetes. NAFLD is considered an emerging risk factor for type 2 diabetes mellitus and a contributor to the development of chronic diabetes-related complications. This reciprocal relationship demonstrates the importance of confirming suspected NAFLD in patients with diabetes. Due to the invasive nature of liver biopsy to assess NAFLD status, various alternative non-invasive modalities have been developed and validated. Here, we summarized the epidemiology of NAFLD in patients with diabetes and reviewed currently available imaging modalities and biomarker-based prediction models for their ability to detect liver steatosis and/or fibrosis.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/2647)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.